• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHOU Yang,ZHU Junbo,LI Xiangyang.[J].Journal Of Pharmaceutical Research,2021,40(4):255-261[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2413times   Download 2323次 QR Code for this article
Scan with your phone!
抗幽门螺杆菌的用药研究进展
周杨1,朱俊博1,李向阳1,2
Font:Larger+|Default|Smaller-
(1.青岛大学医学院,青岛 西宁 810001;三江源生态与高原农牧业国家重点实验室,青海 西宁810016)
摘要:
幽门螺杆菌(Helicobacter pylori, Hp) 感染不仅与胃炎、消化性溃疡、胃癌等消化系统疾病关系密切,还与缺血性心脑血管疾病、脑出血、糖尿病等多种非消化系统疾病有关。目前用于根除幽门螺杆菌感染的药物主要有质子泵抑制剂、抗生素、铋剂、益生菌及中药等。然而,面对我国基数庞大的感染人口,幽门螺杆菌的根除率却在逐年下降,因此越来越多的联合用药方案被应用于临床治疗。本文将从抗幽门螺杆菌药物、联合用药方案以及药物相互作用等方面进行综述。
关键词:  幽门螺杆菌  抗幽门螺杆菌  联合用药  药物相互作用
DOI:10.13506/j.cnki.jpr.2021.04.012
基金项目:国家自然科学基金(No.81760673);青海省自然科学基金(No.2019-ZJ-918)
Publication Date:April 25, 2021
ZHOU Yang1,ZHU Junbo1,LI Xiangyang1,2
()
Abstract:
Key words:  
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.